Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HALO
ICLR
Add up to 3 more stocks
HALO
Halozyme Therapeutics, Inc.
+0.74%
$109.11+0.80Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.94B
52W Range
$61.23 - $116.85
ICLR
ICON Public Limited Company
-3.60%
$162.26-6.07Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.42B
52W Range
$66.57 - $203.91
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 32.57 | 38.09 |
| Forward P/E | 12.97 | 15.32 |
| PEG Ratio | 1.42 | N/A |
| P/B Ratio | 90.16 | 1.32 |
| P/S Ratio | 7.78 | 1.51 |
| P/FCF Ratio | 16.05 | 9.23 |
| EV/EBITDA | 14.15 | 10.61 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 78.2% | 21.9% |
| Operating Margin | 56.8% | 10.2% |
| Net Margin | 24.9% | 4.0% |
| ROE | 288.1% | 3.5% |
| ROA | 16.1% | 2.0% |
| ROIC | 27.4% | 4.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.71 | 0.95 |
| Quick Ratio | 2.31 | 0.95 |
| Debt/Equity | 14.95 | 0.37 |
| Interest Coverage | 45.03 | 5.38 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.